Osteoporosis Among Patients With Diabetes: An Overlooked Disease
- Diane L. Chau, MD,
- Jordi Goldstein-Fuchs, DSc, RD and
- Steven V. Edelman, MD
Abstract
Although osteoporosis is the most prevalent metabolic bone disease in the United States, its impact in a people with diabetes is not often considered. Routine screening or initiation of preventive medications for osteoporosis in all patients with type 1 or type 2 diabetes is not recommended at this time. However, all patients with diabetes, and particularly those with fractures, should be given general recommendations regarding adequate dietary calcium intake, regular exercise, and avoidance of other potential risk factors. Consideration of bone density evaluation should be part of the fracture evaluation, and respective preventive or therapeutic interventions should be applied.
Footnotes
-
Diane L. Chau, MD, is an assistant professor of medicine in the Division of Geriatric Medicine at the University of Nevada School of Medicine and the Geriatric Education Director at the VA Sierra Health Care Systems in Reno, Nev. Jordi Goldstein-Fuchs, DSc, RD, is an associate research professor in the Division of Medical Nutrition at the University of Nevada School of Medicine. Steven V. Edelman, MD, is a professor of medicine in the Division of Endocrinology and Metabolism at the University of California, San Diego, and the Division of Endocrinology and Metabolism at San Diego VA Health Care Systems.
- American Diabetes Association
